Merck (MRK) Non-Current Deferred Tax Liability (2016 - 2025)
Historic Non-Current Deferred Tax Liability for Merck (MRK) over the last 17 years, with Q3 2025 value amounting to $1.4 billion.
- Merck's Non-Current Deferred Tax Liability rose 5983.8% to $1.4 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $1.4 billion, marking a year-over-year increase of 5983.8%. This contributed to the annual value of $1.4 billion for FY2024, which is 5311.02% down from last year.
- According to the latest figures from Q3 2025, Merck's Non-Current Deferred Tax Liability is $1.4 billion, which was up 5983.8% from $1.4 billion recorded in Q2 2025.
- Merck's 5-year Non-Current Deferred Tax Liability high stood at $5.0 billion for Q4 2021, and its period low was $864.0 million during Q3 2024.
- For the 5-year period, Merck's Non-Current Deferred Tax Liability averaged around $1.9 billion, with its median value being $1.4 billion (2025).
- In the last 5 years, Merck's Non-Current Deferred Tax Liability surged by 15506.64% in 2022 and then crashed by 6650.98% in 2023.
- Quarter analysis of 5 years shows Merck's Non-Current Deferred Tax Liability stood at $5.0 billion in 2021, then fell by 14.19% to $4.3 billion in 2022, then plummeted by 31.32% to $3.0 billion in 2023, then tumbled by 53.11% to $1.4 billion in 2024, then dropped by 0.43% to $1.4 billion in 2025.
- Its Non-Current Deferred Tax Liability stands at $1.4 billion for Q3 2025, versus $1.4 billion for Q2 2025 and $1.4 billion for Q1 2025.